Skip to main content

Biosimilars in Medicare Part D: Pricing dynamics and considerations

By Kevin Pierce
14 December 2021

About the Author(s)

Kevin Pierce

Hartford Tel: 1 860 6870190

View bio

We’re here to help

Ask the tough questions. We’re ready for them.

popup image